Radioisotope delivery system with multiple detectors to detect gamma and beta emissions

1. An infusion system comprising:

a frame that carries a beta detector, a gamma detector, an eluate-receiving container, and a waste container and is further configured to receive a radioisotope generator that generates radioactive eluate via elution,

wherein the beta detector is positioned to measure beta emissions emitted from the radioactive eluate, and

the gamma detector is positioned to measure gamma emissions emitted from a portion of the radioactive eluate received in the eluate receiving container to evaluate a safety of the radioactive eluate delivered by the infusion system to ensure that the radioactive eluate generated by the radioisotope generator is safe for patient infusion.

2. The infusion system of claim 1 , further comprising an infusion tubing line configured to receive the radioactive eluate, either directly or indirectly, from the radioisotope generator, when the radioisotope generator is received by the frame.

3. The infusion system of claim 2 , wherein the eluate-receiving container is in fluid communication with the infusion tubing line to receive the portion of the radioactive eluate, thereby providing a static portion of radioactive liquid for evaluation by the gamma detector.

4. The infusion system of claim 3 ,

wherein the beta detector is positioned to measure beta emissions emitted from radioactive eluate flowing through the infusion tubing line; and

the gamma detector is positioned to measure gamma emissions emitted from the portion of radioactive eluate received by the eluate-receiving container.

5. The infusion system of claim 3 , wherein the eluate-receiving container comprises a vial, the infusion tubing line comprises a needle at its end, and the needle on the infusion tubing line is inserted into the vial.

6. The infusion system of claim 3 , wherein

infusion tubing line is part of an infusion tubing circuit that includes an eluate line, a waste line, and a multi-way divergence valve,

when the radioisotope generator is received by the frame, the infusion tubing line is in fluid communication with the eluate line via the multi-way divergence valve and the waste line is in fluid communication with the eluate line via the multi-way divergence valve,

the infusion tubing line is connected to the eluate-receiving container, and

the waste line is connected to the waste container.

7. The infusion system of claim 3 , further comprising a cabinet structure housing at least the radioisotope generator, the infusion tubing line, the eluate-receiving container, the beta detector, and the gamma detector.

8. The infusion system of claim 7 , wherein the cabinet structure has a top surface having an opening formed therein through which the eluate-receiving container is configured to be removed and inserted.

9. The infusion system of claim 8 , wherein the cabinet structure has a door configured to selectively open and close to provide access to the eluate-receiving container.

10. The infusion system of claim 9 , wherein the door is configured to open upwardly with respect to gravity.

11. The infusion system of claim 1 , further comprising the radioisotope generator received by the frame.

12. The infusion system of claim 11 , wherein the radioisotope generator is a strontium-rubidium radioisotope generator configured to generate radioactive eluate containing rubidium-82 via elution of a column containing strontium-82.

13. The infusion system of claim 1 , further comprising a controller in electronic communication with the gamma detector, wherein the controller is configured to determine an activity of strontium in the portion of radioactive eluate based on the gamma emissions measured from the portion of radioactive eluate.

14. The infusion system of claim 13 , wherein the controller is configured to determine an activity of at least one of strontium-82 and strontium-85 in the portion of radioactive eluate and evaluate the safety of the radioactive eluate based on the determined activity.

15. The infusion system of claim 14 , wherein the controller is configured to prevent a patient infusion procedure if the determined activity of at least one of strontium-82 and strontium-85 exceeds an allowable limit.

16. The infusion system of claim 13 , further comprising a touchscreen in communication with the controller.

17. The infusion system of claim 1 , further comprising radioactive shielding surrounding the beta detector, the gamma detector, and the radioisotope generator, when the radioisotope generator is received by the frame, the radioactive shielding providing a barrier effective to reduce radiation emitted by the radioisotope generator and the radioactive eluate below a limit allowable for operating personnel.

18. The infusion system of claim 17 , wherein the radioactive shielding comprises a shielding assembly having a plurality of compartments, including a compartment containing the beta detector, a compartment containing the gamma detector, and a compartment containing the radioisotope generator.

19. The infusion system of claim 18 , wherein the frame carries the beta detector and the gamma detector and also receives the radioisotope generator by supporting the shielding assembly which, in turn, is configured to contain the beta detector, the gamma detector, and the radioisotope generator.

20. The infusion system of claim 1 , wherein the radioisotope generator, the beta detector, and the gamma detector are not positioned in a same plane either vertically or horizontally to maximize a distance between the radioisotope generator and the gamma detector.

21. The infusion system of claim 1 , wherein the gamma detector is positioned at a higher elevation than the radioisotope generator and the beta detector is positioned between the radioisotope generator and the gamma detector, when the radioisotope generator is received by the frame.

22. The infusion system of claim 1 , wherein the eluate-receiving container is positioned over the gamma detector.